James D. Crapo
Department of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
  • 5280 Top Doctors 2016
  • Recognized as a 5280 Top Doctor
  • America’s Top Doctors 2015 — Castle Connolly, Medical, Ltd.
  • Recognized in America’s Top Doctors — Castle Connolly, Inc.
  • Best Doctors in America® 2015 — Best Doctors, Inc.
  • Recognized in Best Doctors in America® — Best Doctors, Inc.
  • America’s Top Doctors 2016 — Castle Connolly Medical, Ltd.
  • Special Interests

    Research Interests

    From 1972 to the present research efforts have focused on mechanisms of oxidative injury and the role of antioxidants in blocking both normal and abnormal oxidative stress. A major emphasis has been on the role of extracellular superoxide dismutase as a regulator of inflammation and of intercellular signal transduction. This laboratory is developing small molecular weight catalytic antioxidants that can be used as drugs and as molecular probes to determine the role of free radicals in normal biology and in disease processes such as radiation-induced injury, stroke, diabetes, chronic lung disease and cancer.

    In 2007, the COPDGene project was launched with Dr. Crapo and Dr. Ed Silverman as principal investigators. COPDGene is an NHLBI funded multi-institutional genetic epidemiology study which will carry out a genome-wide analysis of 10,500 subjects at risk for or with COPD to identify the primary genes that determine risk for developing COPD.


    University of Rochester (New York), MD
    Brigham Young University, BS
    Duke University,
    Harbor General Hospital, Torrance, CA, Internship
    Duke University, Pulmonary Medicine
    National Institute of Environmental Health Sciences, Research Triangle Park, NC, Staff Associate

    Awards & Recognition

    2003-Present: Editor, Journal of Chronic Obstructive Pulmonary Disease

    1999: Presidential Citation, American Thoracic Society

    Board Certification

    American Board of Internal Medicine
    American Board of Pulmonary Diseases

    Professional Memberships

    American Thoracic Society
    American Physiological Society
    American Society for Clinical Investigation
    American College of Physicians
    Fleischner Society
    Association of American Physicians
    American College of Chest Physicians
    The Oxygen Society


    Regan EA, RP Bowler and JD Crapo. Joint fluid antioxidants are decreased in osteoarthritic joints compared to joints with macroscropically intact cartilage and subacute injury. Osteoarthritis Cartilage 16:515-521, 2008.

    Petersen SV, T Kristensen, JS Petersen, L Ramsgaard, TD Oury, JD Crapo, NC Nielsen and JJ Enghild. The folding of human active and inactive extracelluar superoxide dismutases is an extracellular event. J Biol Chem 283:15031-15036, 2008.

    Gridley DS, AY Makinde, X Luo, A Rizvi, JD Crapo, MW Dewhirst, BJ Moeller, RD Pearlstein and JM Slater. Radiation and a metalloporphyrin radioprotectant in a mouse prostate tumor model. Anticancer Research 27:3101-3110, 2007.

    Kinnula VL and JD Crapo. Superoxide dismutases in malignant cells and human tumors. Free Radic Biol Med 36:718-744, 2004.

    Kinnula VL and JD Crapo. Superoxide dismutases in the lung and human diseases. Am J Respir Crit Care Med 167:1600-1619, 2003.

    Academic Affiliations

    Professor of Medicine, University of Colorado Denver

    Teaching & Professional Positions

    1996- present: Professor of Medicine, National Jewish Health, and University of Colorado Denver

    1996- 2008: Director, Clinical Science Graduate Program, University of Colorado Denver

    1996-2004: Associate Dean, School of Medicine, University of Colorado Denver

    1996-2004: Executive Vice President of Academic Affairs, National Jewish Health

    1996-2004: Chair, Department of Medicine, National Jewish Health

    1979-1996: Chief, Division of Allergy, Critical Care and Respiratory Medicine, Duke University, Durham, NC

    Conflicts of Interest

    National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.

    Contact Information

    • Office: 877.225.5654
    • Fax: 303.270.2249



    • National Jewish Health Main Campus
      1400 Jackson St.
      Denver, CO 80206

    Patient Ratings

    The Patient Rating score is an average of all responses to care provider related questions on our independent rating system, the Press Ganey Patient Satisfaction Survey.

    Responses are measured on a scale of 1 to 5, with 5 being the best score. Learn more about our patient satisfaction survey.


    Comments are collected in our Press Ganey Patient Satisfaction Surveys. Patients are de-identified to protect confidentiality and patient privacy. Learn more about our patient satisfaction survey.